For instance, Inhibition of PARP14 (Top one hub node in Table 3, it was found to significantly up-regulated in both diseases) was reported to reduce allergic airway diseases, it thereby was proposed as potential therapeutic target for asthma (Mehrotra et al., 2013). Here, PARP14 is linked to asthma.